GPR55 anticorps (PE-Cy7)
Aperçu rapide pour GPR55 anticorps (PE-Cy7) (ABIN899551)
Antigène
Voir toutes GPR55 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Réactivité croisée
- Humain
-
Homologie
- Mouse,Rat,Dog,Horse,Chicken,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human GPR55
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
FCM(1:100-500)
Optimal working dilution should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- GPR55 (G Protein-Coupled Receptor 55 (GPR55))
-
Autre désignation
- GPR55
-
Sujet
-
Synonyms: LPIR1, G-protein coupled receptor 55, GPR55
Background: May be involved in hyperalgesia associated with inflammatory and neuropathic pain (By similarity). Receptor for L-alpha-lysophosphatidylinositol (LPI). LPI induces Ca(2+) release from intracellular stores via the heterotrimeric G protein GNA13 and RHOA. Putative cannabinoid receptor. May play a role in bone physiology by regulating osteoclast number and function.
-
Poids moléculaire
- 37kDa
-
ID gène
- 9290
-
UniProt
- Q9Y2T6
Antigène
-